Literature DB >> 24400773

Worldwide HLA-E nucleotide and haplotype variability reveals a conserved gene for coding and 3' untranslated regions.

L P Felício1, I O P Porto, C T Mendes-Junior, L C Veiga-Castelli, K E Santos, R P Vianello-Brondani, A Sabbagh, P Moreau, E A Donadi, E C Castelli.   

Abstract

The human leukocyte antigen-E (HLA-E) locus is a human major histocompatibility complex (MHC) gene associated with immune-modulation and suppression of the immune response by the interaction with specific natural killer (NK) and T cell receptors (TCRs). It is considered one of the most conserved genes of the human MHC; however, this low nucleotide variability seems to be a consequence of the scarce number of studies focusing on this subject. In this manuscript we assessed the nucleotide variability at the HLA-E coding and 3' untranslated regions (3'UTRs) in Brazil and in the populations from the 1000Genomes Consortium. Twenty-eight variable sites arranged into 33 haplotypes were detected and most of these haplotypes (98.2%) are encoding one of the two HLA-E molecules found worldwide, E*01:01 and E*01:03. Moreover, three worldwide spread haplotypes, associated with the coding alleles E*01:01:01, E*01:03:01 and E*01:03:02, account for 85% of all HLA-E haplotypes, suggesting that they arose early before human speciation. In addition, the low nucleotide diversity found for the HLA-E coding and 3'UTR in worldwide populations suggests that the HLA-E gene is in fact a conserved gene, which might be a consequence of its key role in the modulation of the immune system.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  haplotypes; human leukocyte antigen-E; lineages; natural selection; variability

Mesh:

Substances:

Year:  2014        PMID: 24400773     DOI: 10.1111/tan.12283

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  HLA-E: a novel player for histocompatibility.

Authors:  Thomas Kraemer; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-10-20       Impact factor: 4.818

Review 2.  Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.

Authors:  Angelique Hölzemer; Wilfredo F Garcia-Beltran; Marcus Altfeld
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

Review 3.  HLA-E: exploiting pathogen-host interactions for vaccine development.

Authors:  H R Sharpe; G Bowyer; S Brackenridge; T Lambe
Journal:  Clin Exp Immunol       Date:  2019-04-09       Impact factor: 4.330

4.  HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.

Authors:  Hana Rohn; Rafael Tomoya Michita; Sabine Schramm; Sebastian Dolff; Anja Gäckler; Johannes Korth; Falko M Heinemann; Benjamin Wilde; Mirko Trilling; Peter A Horn; Andreas Kribben; Oliver Witzke; Vera Rebmann
Journal:  Cells       Date:  2019-08-07       Impact factor: 6.600

5.  HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.

Authors:  Paloma Martín; Isabel Krsnik; Belen Navarro; Mariano Provencio; Juan F García; Carmen Bellas; Carlos Vilches; Natalia Gomez-Lozano
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

6.  HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Authors:  Thomas Kraemer; Alexander A Celik; Trevor Huyton; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Stem Cells Int       Date:  2015-08-12       Impact factor: 5.443

7.  The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.

Authors:  Alexander A Celik; Thomas Kraemer; Trevor Huyton; Rainer Blasczyk; Christina Bade-Döding
Journal:  Immunogenetics       Date:  2015-11-09       Impact factor: 2.846

Review 8.  Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors:  Nicole B Crux; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-07-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.